Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01888003 · ClinicalTrials.gov registry record · NA
The Benefits of a Preoperative Anemia Management Program
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01888003 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 51 participants.
The verdict
NCT01888003, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The goal of this study is to gain further insight into the comparative effectiveness of treating patients, who are found to be anemic before their elective surgery, with a series of weekly subcutaneous doses of a drug given before surgery, which stimulates the natural production of red blood cells (a so-called erythropoietic stimulating agent \[ESA\]) along with intravenous iron, in reducing the need for blood transfusions (donated by someone other than the patient) during and after adult total hip arthroplasty (hip replacement surgery). The effects of a Preoperative Anemia Management Program (PAMP) on the patient's quality of recovery, health-related quality of life, fatigue, and rehabilitation pattern after surgery will also be examined. A cost-effectiveness analysis will be performed to compare the cost of these commercially available, FDA-approved medications versus the cost of transfused blood
Interventions
- DRUG Iron sucrose
- DRUG Epoetin Alfa
- OTHER Blood Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01888003
The ClinicalTrials.gov registry entry for NCT01888003 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Iron sucrose is the first listed.
NCT01888003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01888003 about?
NCT01888003 is a clinical study titled "The Benefits of a Preoperative Anemia Management Program". The goal of this study is to gain further insight into the comparative effectiveness of treating patients, who are found to be anemic before their elective surgery, with a series of weekly subcutaneous doses of a drug given before surgery, which stimulates the natural production of red blood cells (...
What is the current status of trial NCT01888003?
This trial is currently terminated. It is a NA study. The enrollment target is 51 participants. The study started on 2013-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01888003?
The interventions under investigation include: Iron sucrose (DRUG), Epoetin Alfa (DRUG), Blood Transfusion (OTHER).
Who is sponsoring clinical trial NCT01888003?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.